What components make up the medication Cosopt?

Cosopt is a combination medication specifically formulated for the treatment of elevated intraocular pressure in conditions like glaucoma. The formulation of Cosopt includes two main components: a carbonic anhydrase inhibitor and a beta-blocker. The carbonic anhydrase inhibitor in Cosopt helps to reduce the production of aqueous humor, which lowers intraocular pressure. The beta-blocker further aids in decreasing the formation of fluids within the eye as well as improving the outflow of aqueous humor.

Understanding the mechanisms of these two classes of drugs is crucial for effective treatment of elevated eye pressure. By combining these two types, Cosopt effectively manages intraocular pressure through complementary actions that enhance the overall effect of lowering pressure compared to using either agent alone.